- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05858541
The Effects of Music Listening on Anxiety and Agitation in People With Mild and Moderate Cognitive Impairment
October 25, 2023 updated by: Assal Habibi, University of Southern California
Advancing age is associated with an increased risk of developing dementia which can lead to a rapid acceleration in both the healthcare costs and caregiver burden.
There is a need to develop non-pharmacological and easily accessible modalities of support for the well-being and enhancing quality of life for individuals with dementia.
There is evidence that music listening is associated with stress and anxiety reduction in older adults.
Here, the investigators aim to assess the effects of music listening as provided by a novel digital music-based intervention (developed by LUCID) on mood, anxiety, and quality of life in individuals at the early stages of dementia.
LUCID uses reinforcement learning machine learning to curate and personalize the musical playlist while incorporating monoaural theta auditory beat stimulation (ABS) into the music.
The study will be conducted remotely with study hardware (tablets and Bluetooth speakers) being delivered to caregivers/participants.
The study will take place over an 8- week period, with participants completing four 30 mins music or audiobook listening sessions per week.
Pre and post-intervention assessments will be done via Zoom with the presence of a research staff member.
The control condition consists of a randomized list of short audiobooks.
The experimental condition consists of music and monoaural ABS curated by LUCID's AI system.
The investigators hypothesize that the LUCID AI music curation system, compared to audiobooks, will be correlated with a greater reduction in measures of anxiety and agitation and an enhancement of mood and quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Assal Habibi
- Phone Number: 2137403588
- Email: ahabibi@usc.edu
Study Locations
-
-
California
-
Los Angeles, California, United States, 90089
- Recruiting
- University of Southern California
-
Contact:
- Assal Habibi
- Phone Number: 213-740-3588
- Email: ahabibi@usc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Mild to Moderate Cognitive Impairment (mild: MOCA scores (18-25); moderate: MOCA scores (10-17))
- Aged 65-85.
Exclusion Criteria:
- Unmanaged hearing loss (defined as the average pure-tone average threshold of 35 dB HL or greater without the use of hearing instruments or personal sound amplification product) - self-report
- Severe Tinnitus
- Hyperacusis
- Current (but not prior) severe psychiatric disorder, an unstable or serious medical condition that may limit participation in the assessments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Music Listening
Music Intervention - Music selection by LUCID The AI-based system for song selection responds to the collected measurement data (video and HRV) and music preference information (like/dislike button, music taste profile) to recommend the playlist for the listener.
The songs are selected using 76 different musical features and raw audio information.
The system uses these features to recommend and optimize recommendations for the listener.
The video is only temporarily streamed from the device to extract a series of facial features to assist in music selection.
This data stream is sent to the LUCID cloud platform via encrypted data in transit protocol; the facial features are extracted, and the video is deleted.
The facial feature data, even when reconstructed, is not identifiable.
No personally identifiable biometric measures are stored in LUCID servers at any time
|
The LUCID AI-based system for song selection responds to the collected measurement data (video and HRV) and music preference information (like/dislike button, music taste profile) to recommend the playlist for the listener.
The songs are selected using 76 different musical features and raw audio information.
The system uses these features to recommend and optimize recommendations for the listener
|
Active Comparator: Audiobooks
Audiobook selection A selection of 40 audiobooks spanning 4 genres (10 each from Literary Classics, Fantasy, Mystery, Non-fiction) will be available.
For each session, the participant and their caregiver will be given a prompt to make a genre selection.
After making the genre selection, one of the ten stories associated with that genre will be selected at random.
All stories were sampled from the Audible audiobook database.
Stories had to be 30 minutes in length to align with the length of the music interventions and the selected stories had to have had a 4- or 5-star rating to ensure quality.
|
A selection of 40 audiobooks spanning 4 genres (10 each from Literary Classics, Fantasy, Mystery, Non-fiction) will be available.
For each session, the participant and their caregiver will be given a prompt to make a genre selection.
After making the genre selection, one of the ten stories associated with that genre will be selected at random.
All stories were sampled from the Audible audiobook database.
Stories had to be 30 minutes in length to align with the length of the music interventions and the selected stories had to have had a 4- or 5-star rating to ensure quality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Agitation Trait
Time Frame: 8 weeks
|
Change in agitation as measured by the Cohen-Mansfield Agitation Index
|
8 weeks
|
Agitation State
Time Frame: pre and post 20 mins session for a total of 32 sessions
|
Change in agitation as measured by Overt Agitation Scale (OAS)
|
pre and post 20 mins session for a total of 32 sessions
|
Agitation State
Time Frame: pre and post 20 mins session for a total of 32 sessions
|
Change in agitation as measured by Positive and Negative Syndrome Scale, Excited Component (PANSS-EC)
|
pre and post 20 mins session for a total of 32 sessions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety
Time Frame: 8 weeks
|
Change in Anxiety in Dementia Scale (RAID)-Minimum value: 0, Maximum value: 54.
Higher score
|
8 weeks
|
Anxiety
Time Frame: 8 weeks
|
Change in State-trait cognitive and somatic anxiety (STICSA)
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: 8 weeks
|
Change in depression as measured by Geriatric Depression Scale 0 is minimum and 15 is maximum with 15 being highest rate of depression
|
8 weeks
|
Well-being
Time Frame: 8 weeks
|
Change in quality of life as measured by Cornell Brown Scale for Quality of Life in Dementia - Minimum score: -38.
Maximum score: 38.
Higher score indicates better outcome (increased quality of life)
|
8 weeks
|
Caregiver Burden
Time Frame: 8 weeks
|
Change in caregiver burden measured by Zarit caregiver burden
|
8 weeks
|
Anxiety and Mood
Time Frame: pre and post 20 mins session for a total of 32 sessions
|
Change in Mood and Anxiety as measured by PANAS Positive and Negative Affect Schedule
|
pre and post 20 mins session for a total of 32 sessions
|
Arousal
Time Frame: pre and post 20 mins session for a total of 32 sessions
|
Change in affect as measured by high low arousal
|
pre and post 20 mins session for a total of 32 sessions
|
Valence
Time Frame: pre and post 20 mins session for a total of 32 sessions
|
Change in affect as measured by positive negative valence
|
pre and post 20 mins session for a total of 32 sessions
|
Memory
Time Frame: 8 weeks
|
Changes in memory recall measured by vividness and specificity of recalled memories
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
November 1, 2023
Study Completion (Estimated)
December 30, 2023
Study Registration Dates
First Submitted
April 28, 2023
First Submitted That Met QC Criteria
May 10, 2023
First Posted (Actual)
May 15, 2023
Study Record Updates
Last Update Posted (Actual)
October 30, 2023
Last Update Submitted That Met QC Criteria
October 25, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APP-23-02029
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
The data and protocol will be available upon completion of the data and analysis
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Loma Linda UniversityCompletedParental/Caregiver Anxiety | Child's AnxietyUnited States
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
Clinical Trials on Music Listening
-
Inonu UniversityCompletedCancer | ChemotherapyTurkey
-
Anglia Ruskin UniversityCompletedDepression | Stress | Anxiety | Visual Impairment | Low Vision | Emotional AdjustmentUnited Kingdom
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Aydin Adnan Menderes UniversityCompletedPain | Anxiety | Nurse's RoleTurkey
-
Erasmus Medical CenterNot yet recruiting
-
University of British ColumbiaNortheastern UniversityRecruiting
-
Turku University HospitalAcademy of FinlandCompleted
-
University Hospitals Cleveland Medical CenterKulas FoundationCompleted
-
University of British ColumbiaVancouver Coastal Health Research Institute; Mary Pack Research FundCompletedArthritis, Rheumatoid | Arthritis, Psoriatic | Spondylarthropathies | Inflammatory ArthritisCanada
-
The Hong Kong Polytechnic UniversityCompleted